MEHRADADIBIMEHRAD ADIBI11864ADIBI, MEHRADAssistant Professorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonGenitourinary Medical OncologyMD AndersonCHRISTOPHER GWOODCHRISTOPHER G WOOD8666WOOD, CHRISTOPHER GProfessorERICJONASCHERIC JONASCH9049JONASCH, ERICProfessorPHEROZETAMBOLIPHEROZE TAMBOLI8780TAMBOLI, PHEROZEProfessorNIZAR MTANNIRNIZAR M TANNIR8865TANNIR, NIZAR MProfessorSURENAMATINSURENA MATIN9030MATIN, SURENAProfessorCURTIS APETTAWAYCURTIS A PETTAWAY8468PETTAWAY, CURTIS AProfessorJOSE ANTONIOKARAMJOSE ANTONIO KARAM9608KARAM, JOSE ANTONIOAssociate Professor22882743Adibi M, Youssef R, Shariat SF, Lotan Y, Wood CG, Sagalowsky AI, Zigeuner R, Montorsi F, Bolenz C, Margulis VInternational journal of urology : official journal of the Japanese Urological AssociationOncological outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: comparison over the three decades. Int J Urol. 2012 Dec; 19(12):1060-6.Int J Urol2012-08-12T00:00:002012Oncological outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: comparison over the three decades.25454608Adibi M, Karam JA, Wood CGEuropean urologyReporting geographic and temporal trends in renal cell carcinoma: why is this important? Eur Urol. 2015 Mar; 67(3):531-2.Eur Urol2014-10-29T00:00:002014Reporting geographic and temporal trends in renal cell carcinoma: why is this important?25758610Thomas AZ, Adibi M, Borregales LD, Hoang LN, Tamboli P, Jonasch E, Tannir NM, Matin SF, Wood CG, Karam JAThe Journal of urologySurgical Management of Local Retroperitoneal Recurrence of Renal Cell Carcinoma after Radical Nephrectomy. J Urol. 2015 Aug; 194(2):316-22.J Urol2015-03-07T00:00:002015Surgical Management of Local Retroperitoneal Recurrence of Renal Cell Carcinoma after Radical Nephrectomy.26004164Adibi M, Thomas AZ, Borregales LD, Merrill MM, Slack RS, Chen HC, Sircar K, Murugan P, Tamboli P, Jonasch E, Tannir NM, Matin SF, Wood CG, Karam JAUrologic oncologyPercentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiation. Urol Oncol. 2015 Oct; 33(10):427.e17-23.Urol Oncol2015-05-23T00:00:002015Percentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiation.26125508Thomas AZ, Adibi M, Borregales LD, Wood CG, Karam JACurrent opinion in urologyRole of metastasectomy in metastatic renal cell carcinoma. Curr Opin Urol. 2015 Sep; 25(5):381-9.Curr Opin Urol2015-09-01T00:00:002015Role of metastasectomy in metastatic renal cell carcinoma.26382085Adibi M, Kenney PA, Thomas AZ, Borregales LD, Nogueras-Gonz?lez GM, Wang X, Devine CE, Karam JA, Wood CGEuropean urologyPrediction of Pulmonary Metastasis in Renal Cell Carcinoma Patients with Indeterminate Pulmonary Nodules. Eur Urol. 2016 Feb; 69(2):352-60.Eur Urol2015-09-14T00:00:002015Prediction of Pulmonary Metastasis in Renal Cell Carcinoma Patients with Indeterminate Pulmonary Nodules.26546481Adibi M, Thomas AZ, Borregales LD, Matin SF, Wood CG, Karam JAUrologic oncologySurgical considerations for patients with metastatic renal cell carcinoma. Urol Oncol. 2015 Dec; 33(12):528-37.Urol Oncol2015-11-03T00:00:002015Surgical considerations for patients with metastatic renal cell carcinoma.74Professor10Assistant Professor14Associate Professor1515 Holcombe Blvd.Houston77030TX1.455060.00485813121research areas2.30470.047672826coauthor of88.6725.1342860similar to1144selected publicationsAuthorship 3725911Authorship 3727261Authorship 3727272Authorship 841476Authorship 850657Authorship 853873Authorship 855027Authorship 855053Authorship 859827Authorship 861008Authorship 862386Authorship 866046Urologic Oncology: Seminars and Original InvestigationsPrognosticators and outcomes of patients with renal cell carcinoma and adjacent organ invasion treated with radical nephrectomy. Urologic Oncology: Seminars and Original Investigations. Prognosticators and outcomes of patients with renal cell carcinoma and adjacent organ invasion treated with radical nephrectomyJournal of Adolescent and Young Adult OncologyDo referral patterns in adolescents and young adults with testicular cancer impact oncologic outcomes?. Journal of Adolescent and Young Adult Oncology. 5:248-253.Do referral patterns in adolescents and young adults with testicular cancer impact oncologic outcomes?Urologic Oncology: Seminars and Original InvestigationsPercentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiation. Urologic Oncology: Seminars and Original Investigations. 33:427.e17-427.e23.Percentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiationAdaptive multi-affine (AMA) feature-matching algorithm and its application to minimally-invasive surgery images. 2371-2376.Adaptive multi-affine (AMA) feature-matching algorithm and its application to minimally-invasive surgery imagesJournal of UrologySurgical Management of Local Retroperitoneal Recurrence of Renal Cell Carcinoma after Radical Nephrectomy. Journal of Urology. Surgical Management of Local Retroperitoneal Recurrence of Renal Cell Carcinoma after Radical NephrectomyJournal of UrologyThe Role of Metastasectomy in Patients with Renal Cell Carcinoma with Sarcomatoid Dedifferentiation. Journal of Urology. The Role of Metastasectomy in Patients with Renal Cell Carcinoma with Sarcomatoid DedifferentiationEuropean UrologyPrediction of Pulmonary Metastasis in Renal Cell Carcinoma Patients with Indeterminate Pulmonary Nodules. European Urology. Prediction of Pulmonary Metastasis in Renal Cell Carcinoma Patients with Indeterminate Pulmonary NodulesTherapeutic Advances in UrologyThe role of neoadjuvant therapy in the management of locally advanced renal cell carcinoma. Therapeutic Advances in Urology. 8:130-141.The role of neoadjuvant therapy in the management of locally advanced renal cell carcinomaTranslational Andrology and UrologyCytoreductive surgery in the era of targeted molecular therapy. Translational Andrology and Urology. 4:301-309.Cytoreductive surgery in the era of targeted molecular therapyAuthorship 8870021Authorship 8872162Authorship 8875971Authorship 8891101D009392Procedures1837740.685442NephrectomyD002292Disorders43523160.406881Carcinoma, Renal CellD007680Disorders57130110.367868Kidney NeoplasmsD014516Disorders402280.829962Ureteral NeoplasmsAuthorship 8989913Authorship 9005681Authorship 9007763Authorship 9009172Authorship 9009682Authorship 9010181Authorship 9017331Authorship 9019463Authorship 9024535Authorship 9029443Authorship 9035165Authorship 9041776Authorship 9043812Authorship 9063253Authorship 9091052Authorship 9091142Authorship 918343217997440Lucas SM, Stern JM, Adibi M, Zeltser IS, Cadeddu JA, Raj GVThe Journal of urologyRenal function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques. J Urol. 2008 Jan; 179(1):75-9; discussion 79-80.J Urol2007-11-13T00:00:002007Renal function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques.22115356Adibi M, Pearle MS, Lotan YBJU internationalCost-effectiveness of standard vs intensive antibiotic regimens for transrectal ultrasonography (TRUS)-guided prostate biopsy prophylaxis. BJU Int. 2012 Jul; 110(2 Pt 2):E86-91.BJU Int2011-11-24T00:00:002011Cost-effectiveness of standard vs intensive antibiotic regimens for transrectal ultrasonography (TRUS)-guided prostate biopsy prophylaxis.22365444Adibi M, Hudak SJ, Morey AFUrologyPenile plication without degloving enables effective correction of complex Peyronie's deformities. Urology. 2012 Apr; 79(4):831-5.Urology2012-02-25T00:00:002012Penile plication without degloving enables effective correction of complex Peyronie's deformities.22840865Cost NG, Adibi M, Lubahn JD, Romman A, Raj GV, Sagalowsky AI, Margulis VUrologyEffect of testicular germ cell tumor therapy on renal function. Urology. 2012 Sep; 80(3):641-8.Urology2012-07-26T00:00:002012Effect of testicular germ cell tumor therapy on renal function.22455405Lotan Y, Adibi M, Pearle MSBJU internationalReply. BJU Int. 2012 Apr; 109(8):E26-7.BJU Int2012-04-01T00:00:002012Reply.23290141Olweny EO, Kapur P, Tan YK, Park SK, Adibi M, Cadeddu JAUrologyIrreversible electroporation: evaluation of nonthermal and thermal ablative capabilities in the porcine kidney. Urology. 2013 Mar; 81(3):679-84.Urology2013-01-03T00:00:002013Irreversible electroporation: evaluation of nonthermal and thermal ablative capabilities in the porcine kidney.22982426Adibi M, Hornberger B, Bhat D, Raj G, Roehrborn CG, Lotan YThe Journal of urologyReduction in hospital admission rates due to post-prostate biopsy infections after augmenting standard antibiotic prophylaxis. J Urol. 2013 Feb; 189(2):535-40.J Urol2012-10-08T00:00:002012Reduction in hospital admission rates due to post-prostate biopsy infections after augmenting standard antibiotic prophylaxis.23017514Hudak SJ, Morey AF, Adibi M, Bagrodia AThe Journal of urologyFavorable patient reported outcomes after penile plication for wide array of peyronie disease abnormalities. J Urol. 2013 Mar; 189(3):1019-24.J Urol2012-09-24T00:00:002012Favorable patient reported outcomes after penile plication for wide array of peyronie disease abnormalities.24074987Seideman CA, Zhao LC, Hudak SJ, Mierzwiak J, Adibi M, Morey AFUrologyIs prolonged catheterization a risk factor for artificial urinary sphincter cuff erosion? Urology. 2013 Oct; 82(4):943-6.Urology2013-10-01T00:00:002013Is prolonged catheterization a risk factor for artificial urinary sphincter cuff erosion?24106160Cost NG, Lubahn JD, Adibi M, Romman A, Wickiser JE, Raj GV, Sagalowsky AI, Margulis VPediatric blood & cancerA comparison of pediatric, adolescent, and adult testicular germ cell malignancy. Pediatr Blood Cancer. 2014 Mar; 61(3):446-51.Pediatr Blood Cancer2013-09-17T00:00:002013A comparison of pediatric, adolescent, and adult testicular germ cell malignancy.24679874Cost NG, Lubahn JD, Adibi M, Romman A, Wickiser JE, Raj GV, Sagalowsky AI, Margulis VThe Journal of urologyRisk stratification of pubertal children and postpubertal adolescents with clinical stage I testicular nonseminomatous germ cell tumors. J Urol. 2014 May; 191(5 Suppl):1485-90.J Urol2014-03-26T00:00:002014Risk stratification of pubertal children and postpubertal adolescents with clinical stage I testicular nonseminomatous germ cell tumors.26815334Thomas AZ, Adibi M, Borregales LD, Karam JA, Wood CGTranslational andrology and urologyCytoreductive surgery in the era of targeted molecular therapy. Transl Androl Urol. 2015 Jun; 4(3):301-9.Transl Androl Urol2015-06-01T00:00:002015Cytoreductive surgery in the era of targeted molecular therapy.26871870Cost NG, Caldwell BT, Adibi M, Raj GV, Sagalowsky AI, Margulis VJournal of adolescent and young adult oncologyDo Referral Patterns in Adolescents and Young Adults with Testicular Cancer Impact Oncologic Outcomes? J Adolesc Young Adult Oncol. 2016 09; 5(3):248-53.J Adolesc Young Adult Oncol2016-02-12T00:00:002016Do Referral Patterns in Adolescents and Young Adults with Testicular Cancer Impact Oncologic Outcomes?26707613Borregales LD, Kim DY, Staller AL, Qiao W, Thomas AZ, Adibi M, Tamboli P, Sircar K, Jonasch E, Tannir NM, Matin SF, Wood CG, Karam JAUrologic oncologyPrognosticators and outcomes of patients with renal cell carcinoma and adjacent organ invasion treated with radical nephrectomy. Urol Oncol. 2016 May; 34(5):237.e19-26.Urol Oncol2015-12-18T00:00:002015Prognosticators and outcomes of patients with renal cell carcinoma and adjacent organ invasion treated with radical nephrectomy.27034725Borregales LD, Adibi M, Thomas AZ, Wood CG, Karam JATherapeutic advances in urologyThe role of neoadjuvant therapy in the management of locally advanced renal cell carcinoma. Ther Adv Urol. 2016 Apr; 8(2):130-41.Ther Adv Urol2015-11-20T00:00:002015The role of neoadjuvant therapy in the management of locally advanced renal cell carcinoma.27036304Thomas AZ, Adibi M, Slack RS, Borregales LD, Merrill MM, Tamboli P, Sircar K, Jonasch E, Tannir NM, Matin SF, Wood CG, Karam JAThe Journal of urologyThe Role of Metastasectomy in Patients with Renal Cell Carcinoma with Sarcomatoid Dedifferentiation: A Matched Controlled Analysis. J Urol. 2016 Sep; 196(3):678-84.J Urol2016-03-29T00:00:002016The Role of Metastasectomy in Patients with Renal Cell Carcinoma with Sarcomatoid Dedifferentiation: A Matched Controlled Analysis.28941919Wood EL, Adibi M, Qiao W, Brandt J, Zhang M, Tamboli P, Matin SF, Wood CG, Karam JAThe Journal of urologyLocal Tumor Bed Recurrence Following Partial Nephrectomy in Patients with Small Renal Masses. J Urol. 2018 02; 199(2):393-400.J Urol2017-09-20T00:00:002017Local Tumor Bed Recurrence Following Partial Nephrectomy in Patients with Small Renal Masses.D019072Procedures1391820.860821Antibiotic ProphylaxisPathologyUrologyAuthorship 960510231685445Borregales LD, Adibi M, Thomas AZ, Reis RB, Chery LJ, Devine CE, Wang X, Potretzke AM, Potretzke T, Figenshau RS, Bauman TM, Aboshady YI, Abel EJ, Matin SF, Karam JA, Wood CGEuropean urology focusPredicting Adherent Perinephric Fat Using Preoperative Clinical and Radiological Factors in Patients Undergoing Partial Nephrectomy. Eur Urol Focus. 2021 03; 7(2):397-403.Eur Urol Focus2019-11-02T00:00:002019Predicting Adherent Perinephric Fat Using Preoperative Clinical and Radiological Factors in Patients Undergoing Partial Nephrectomy.Authorship 9937232832631491Kleinmann N, Matin SF, Pierorazio PM, Gore JL, Shabsigh A, Hu B, Chamie K, Godoy G, Hubosky S, Rivera M, O'Donnell M, Quek M, Raman JD, Knoedler JJ, Scherr D, Stern J, Weight C, Weizer A, Woods M, Kaimakliotis H, Smith AB, Linehan J, Coleman J, Humphreys MR, Pak R, Lifshitz D, Verni M, Adibi M, Amin MB, Seltzer E, Klein I, Konorty M, Strauss-Ayali D, Hakim G, Schoenberg M, Lerner SPThe Lancet. OncologyPrimary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial. Lancet Oncol. 2020 06; 21(6):776-785.Lancet Oncol2020-04-29T00:00:002020Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial.Authorship 1009278133476195Adibi M, Matin SFThe Journal of urologyEditorial Comment. J Urol. 2021 04; 205(4):1046.J Urol2021-01-21T00:00:002021Editorial Comment.Authorship 1012082533612354Kokorovic A, Duplisea J, Qiao W, McCormick B, Adibi M, Papadopoulos J, Ramirez G, Rao P, Tamboli P, Pettaway CUrologic oncologyOncologic outcomes and subsequent treatment following organ sparing surgery for penile carcinoma: The University of Texas M.D. Anderson Cancer Center Experience. Urol Oncol. 2021 05; 39(5):302.e19-302.e27.Urol Oncol2021-02-18T00:00:002021Oncologic outcomes and subsequent treatment following organ sparing surgery for penile carcinoma: The University of Texas M.D. Anderson Cancer Center Experience.Authorship 10400611Authorship 1041338235039231Adibi M, McCormick B, Economides MP, Petros F, Xiao L, Guo C, Shah A, Kamat AM, Dinney C, Navai N, Gao J, Siefker-Radtke A, Matin SF, Campbell MTClinical genitourinary cancerFive and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk Upper Tract Urothelial Carcinoma. Clin Genitourin Cancer. 2022 04; 20(2):176-182.Clin Genitourin Cancer2021-12-24T00:00:002021Five and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk Upper Tract Urothelial Carcinoma.35236102Labbate CV, Adibi M, Matin SFThe Journal of urologyEditorial Comment. J Urol. 2022 06; 207(6):1309-1310.J Urol2022-03-03T00:00:002022Editorial Comment.Authorship 10445731135475152Alhalabi O, Campbell MT, Xiao L, Adriazola AC, Wilson NR, Siefker-Radtke AO, Corn PG, Zurita A, Jonasch E, Gao J, Adibi M, Kamat AM, Navai N, Pisters LL, Dinney C, Matin SF, Shah AYBJUI compassMultimodal kidney-preserving approach in localised and locally advanced high-risk upper tract urothelial carcinoma. BJUI Compass. 2022 Jan; 3(1):37-44.BJUI Compass2021-10-11T00:00:002021Multimodal kidney-preserving approach in localised and locally advanced high-risk upper tract urothelial carcinoma.Authorship 10547095Authorship 10555091036285629Rose KM, Narang G, Rosen G, Labatte C, Dumitrascu CI, Campagna J, Yu A, Manley BJ, Spiess PE, Li R, Adibi M, Murray KS, Sexton WJ, Humphreys MRBJU internationalAntegrade administration of mitomycin gel for upper tract urothelial carcinoma via percutaneous nephrostomy tube: a multi-institutional retrospective cohort study. BJU Int. 2023 04; 131(4):471-476.BJU Int2022-11-15T00:00:002022Antegrade administration of mitomycin gel for upper tract urothelial carcinoma via percutaneous nephrostomy tube: a multi-institutional retrospective cohort study.35961847Labbate CV, Hensley PJ, Miest TS, Qiao W, Adibi M, Shah AY, Chery L, Papadopoulos J, Siefker-Radtke AO, Gao J, Guo CC, Czerniak BA, Navai N, Kamat AM, Dinney CP, Campbell MT, Matin SFUrologic oncologyLongitudinal GFR trends after neoadjuvant chemotherapy prior to nephroureterectomy for upper tract urothelial carcinoma. Urol Oncol. 2022 10; 40(10):454.e17-454.e23.Urol Oncol2022-08-10T00:00:002022Longitudinal GFR trends after neoadjuvant chemotherapy prior to nephroureterectomy for upper tract urothelial carcinoma.Authorship 1087824638262868Gregg JR, Magill R, Fang AM, Chapin BF, Davis JW, Adibi M, Ch?ry L, Papadopoulos J, Pettaway C, Pisters L, Ward JF, Hahn AW, Daniel CR, Bhaskaran J, Zhu K, Guerrero M, Zhang M, Troncoso PUrologic oncologyThe association of body mass index with tumor aggression among men undergoing radical prostatectomy. Urol Oncol. 2024 Apr; 42(4):116.e1-116.e7.Urol Oncol2024-01-22T00:00:002024The association of body mass index with tumor aggression among men undergoing radical prostatectomy.Authorship 1089260838388244Ozambela M, McCormick BZ, Rudzinski JK, Pieretti AC, Gonz?lez GMN, Meissner MA, Papadopoulos JN, Adibi M, Matin SF, Dahmen AS, Spiess PE, Pettaway CAUrologic oncologyRobotic or open superficial inguinal lymph node dissection as staging procedures for clinically node negative high risk penile cancer. Urol Oncol. 2024 Apr; 42(4):120.e1-120.e9.Urol Oncol2024-02-22T00:00:002024Robotic or open superficial inguinal lymph node dissection as staging procedures for clinically node negative high risk penile cancer.true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessor